AstraZeneca recently announced that Imfinzi combined with standard-of-care chemotherapy significantly improved overall survival and progression-free survival in patients with advanced biliary tract...
The National Institutes of Health (NIH) recently launched the first phase of Neuromod Prize, a $9.8 million competition to accelerate the development of neuromodulation therapies.
Neuromodulation...
Despite growing provider shortages, pharmacists in the US are well-trusted by patients and projected to play an increasingly crucial role in healthcare management, according to research from Columbia...
The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania Gene Therapy Program (GCP) recently collaborated to advance the discovery and manufacturing of gene therapies.
The...
AstraZeneca recently collaborated with Scorpion Therapeutics to discover, develop, and commercialize precision medicines against previously undruggable targets.
The companies will focus on a class of...
Pfizer and Beam Therapeutics recently entered into a four-year collaboration focused on in vivo base editing programs to generate precision medicine for rare diseases of the liver, muscle, and central...
Pfizer recently announced positive top-line results from a Phase 3 trial studying its COVID-19 vaccine combined with its pneumococcal 20-valent conjugate vaccine, Prevnar 20.
The study, B74710126,...
Thermo Fisher Scientific recently completed the $1.85 billion acquisition of PeproTech to increase its capabilities in the high growth cell and gene therapy market.
PeproTech is a privately held...
As big pharma looks to advance its pipelines of innovative drugs and digital measures, industry cooperation is crucial.
In recent years, pharmaceutical companies have embraced a more collaborative way...
FDA recently approved new expanded magnetic resonance imaging (MRI) compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode Leads.
The Proclaim XR SCS System is...
FDA recently granted emergency use authorization for Siemens Healthineers’ CLINITEST Rapid COVID-19 Antigen Self-Test.
The nasal swab test is a point-of-care cassette test that does not require...
Life Science Biosensor Diagnostics (LSBD), a subsidiary of the iQ Group Global, recently filed an FDA Breakthrough Device Designation application for its Saliva Glucose Biosensor for diabetes care...
FDA recently expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine booster to include individuals 12 years of age and older.
The authorization follows two months after the...
Biogen recently announced that it will reduce the wholesale acquisition cost (WAC) of its Alzheimer’s disease treatment, Aduhelm, in the US by nearly 50 percent.
For a patient of average weight,...
FDA recently sent a warning letter to Medtronic for the headquarters facility of its diabetes business in Northridge, California.
The warning letter focused on the inadequacy of specific medical...
Hackensack Meridian Health recently announced its support of the clinical development of a highly-differentiated immuno-oncology platform from Alloplex Biotherapeutics.
This investment is...
Pfizer and BioNTech recently announced that they will amend the clinical study evaluating the safety, tolerability, and immunogenicity of their COVID-19 vaccine in children.
The Phase 1/2/3 trial...
FDA recently approved ViiV Healthcare’s long-acting injectable pre-exposure prophylaxis (PrEP) treatment, Apretude, to reduce the risk of sexually acquired HIV-1.
The agency approved Apretude...
Bristol Myers Squibb and clinical-stage biopharmaceutical company Immatics recently entered into a license, development, and commercialization agreement for the bispecific T-cell candidate,...
Kite, a Gilead Company, recently announced positive primary results from a Phase 2 study of Yescarta in patients with high-risk large B-cell lymphoma (LBCL).
The global ZUMA-12 study enrolled 42...
